0   /   100

Blog

Evergrowth BioHealthcare Capital LLC 2023 Annual Meeting

Join us for the much-anticipated Annual 2023 Shareholders Meeting in the vibrant setting of Florida on December 27th. This invitation extends to both our valued members and esteemed guests. Immerse yourself in the dynamic atmosphere of the event, where we unveil the latest innovations in the life science sector. Explore firsthand the potential investment opportunities...

Read More about "Evergrowth BioHealthcare Capital LLC 2023 Annual Meeting"

Stock Picking Process

Our fund’s stock-picking process involves an integrated assessment of clinical-stage biotech companies, focusing on the lead drug or “Crown Jewel” of the pipeline. This includes evaluating the drug’s Mechanism of Action, Disease Context, and forecasting its chances of passing through clinical studies and gaining FDA approval. It’s important to have a deep understanding of how...

Read More about "Stock Picking Process"

Long Focus on Common Stocks of U.S.-based Public Equity

Similar to Warren Buffet, our fund approaches stock buying as investing in a piece of a wonderful business. As such, we would acquire mostly long positions for our investment. There are more upsides to going long while having limited risks. By going long, there is a potential to gain multiple folds on an investment. In...

Read More about "Long Focus on Common Stocks of U.S.-based Public Equity"

Deep Specialization and Diversification to Boost Returns

Our deep specialization in life science equity confers sector expertise and thereby positions us to outperform in this niche. Taking specialization to the next level, we concentrate our investment on the “growth biotech” stocks category. This allows us to capture the tremendous upsides in clinical stage and early product bioequities. Growth stocks tend to outperform...

Read More about "Deep Specialization and Diversification to Boost Returns"

Binary Event Forecasting to Boost Returns

To boost our gains, we leverage our expert edge in the forecasting of biotech binary events outcomes. As important catalytic developments for clinical stage biotech companies, these events entail either an FDA approval and significant clinical data report. Whenever a drug either passes through a major clinical hurdle or gains FDA approval, their stock is...

Read More about "Binary Event Forecasting to Boost Returns"

Integrated BioSci Investing Philosophy

Known as Integrated BioSci Investing, our investment practice is inspired by various gurus, including Peter Lynch, Warren Buffett, Phillip Fisher, and Ben Graham. We integrate what we learned from those luminaries with various disciplines (i.e., medical, scientific, and market expertise) that are adapted specifically to biotech investing like a custom-made suit. In our approach, we...

Read More about "Integrated BioSci Investing Philosophy"
DNA Genotyping and Sequencing. Technician prepares for a viral whole-genome sequencing experiment at the Cancer Genomics Research Laboratory, part of the National Cancer Institute's Division of Cancer Epidemiology and Genetics (DCEG).

Invest in the Future of Biotech

Introduction Biotechnology, a rapidly evolving field that combines biology and technology, has the potential to revolutionize various industries and improve our quality of life. From healthcare to agriculture, biotech innovations are transforming the way we live and work. As an investor, recognizing the opportunities in this sector can be highly rewarding. In this blog post,...

Read More about "Invest in the Future of Biotech"